Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001622058-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-20 | 2025-11-18+ | MEDP | Troendle August J. | CEO, Dir, 10% | S - Sale | $591.79 | -31.1K | 886.2K | -3% | -$18.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-19 | S | D | 23,862 | $592.07 | 862,315 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $594.065. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2025-11-18 | S | D | 7,191 | $590.84 | 886,177 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $592.09. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |